No Data
No Data
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
The Pacific Securities: The Sector's profits improved significantly in Q1, and the pharmaceutical industry is expected to see a rapid increase in concentration.
The trend of increasing concentration in the pharmaceutical industry and the strong becoming stronger is expected to continue to strengthen.
Hong Kong stocks fluctuate | CRO Concept stocks fell broadly in early trading, VIVA BIOTECH (01873) dropped over 4%, WUXI APPTEC (02359) fell over 3%.
CRO Concept stocks experienced a general decline in the morning. As of this report, VIVA BIOTECH (01873) fell by 4.58%, priced at 1.46 Hong Kong dollars; WUXI APPTEC (02359) dropped by 3.03%, priced at 62.45 Hong Kong dollars; PHARMARON (03759) decreased by 2.07%, priced at 14.16 Hong Kong dollars.
PHARMARON (03759.HK) will release its Earnings Reports on April 25.
$PHARMARON (03759.HK)$ will release its Earnings Reports on April 25th, and investors are advised to pay attention. How was the performance prior? In Q1 2024, the revenue was 2.671 billion yuan, net income was 0.216 billion yuan, and EPS was 0.130 yuan. Futubull reminds: 1. There are no hard and fast rules regarding the accounting year divisions for companies listed on the Hong Kong and US stock exchanges; it is entirely up to the company to decide, so each report period can serve as the cutoff date for the annual report without being constrained by the calendar year as the fiscal year. 2. Generally, the company will hold an earnings report meeting on the aforementioned report release date or around that date with the company's management.
PHARMARON: 2024 ANNUAL REPORT
Zhitong Hong Kong stock short position statistics | April 28
Zhitong Hong Kong Stock Short Position Holding | April 28